BPMC Blueprint Medicines Corp

USD 96.88 +0.26 ( +0.27)%
Icon

Blueprint Medicines Corp (BPMC) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 96.88

+0.26 (+0.27)%

USD 5.76B

0.37M

USD 122.42(+26.36%)

USD 78.75 (-18.71%)

Icon

BPMC

Blueprint Medicines Corp (USD)
COMMON STOCK | NSD
USD 96.88
+0.26 ( +0.27)%

Blueprint Medicines Corp (BPMC) Stock Forecast

Show ratings and price targets of :
USD 122.42
(+26.36%)

Based on the Blueprint Medicines Corp stock forecast from 9 analysts, the average analyst target price for Blueprint Medicines Corp is USD 122.42 over the next 12 months. Blueprint Medicines Corp’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Blueprint Medicines Corp is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Blueprint Medicines Corp’s stock price was USD 96.88. Blueprint Medicines Corp’s stock price has changed by -2.76% over the past week, +9.09% over the past month and +64.59% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...